Could a common bile acid pill speed up liver recovery from hepatitis?
NCT ID NCT07525401
First seen Apr 24, 2026 · Last updated May 13, 2026 · Updated 4 times
Summary
This study tests whether a medicine called ursodeoxycholic acid (UDCA) can help lower bilirubin levels in people with acute viral hepatitis (types A or E). Bilirubin is a waste product that builds up when the liver is inflamed, causing yellowing of the skin and eyes. The trial will compare 88 adults who get UDCA plus standard care against those who get standard care alone, measuring bilirubin changes after 7 days. If effective, UDCA could become a routine treatment for this condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS A are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.